Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer
1551.6000 10.40 (0.67%)
NSE Sep 09, 2025 15:31 PM
Volume: 788.2K
 

logo
Cipla Ltd.
13 Nov 2017
1551.60
0.67%
Axis Direct
Cipla's Q2 EBITDA margin improved 156 bps YoY at 19.7% (despite 270 bps YoY decline in gross margin) led by operating leverage (higher domestic sales) and increasing cost efficiencies (which it expects to improve further in H2FY18/FY19).
Number of FII/FPI investors increased from 1114 to 1124 in Jun 2025 qtr.
More from Cipla Ltd.
Recommended